Adjuvant Tebentafusp in High Risk Ocular Melanoma
Conditions: Uveal Melanoma Interventions: Drug: Tebentafusp Sponsors: European Organisation for Research and Treatment of Cancer - EORTC; Northwell Health Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eye Cancers | Melanoma | Research | Skin Cancer | Uveal Melanoma